Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Income from Continuing Operations: 2009-2025

Historic Income from Continuing Operations for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to -$38.7 million.

  • Lifecore Biomedical's Income from Continuing Operations rose 83.81% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 514.93%. This contributed to the annual value of -$38.7 million for FY2025, which is 514.93% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Income from Continuing Operations of -$38.7 million as of FY2025, which was down 514.93% from $9.3 million recorded in FY2024.
  • Lifecore Biomedical's Income from Continuing Operations' 5-year high stood at $9.3 million during FY2024, with a 5-year trough of -$64.2 million in FY2023.
  • For the 3-year period, Lifecore Biomedical's Income from Continuing Operations averaged around -$31.2 million, with its median value being -$38.7 million (2025).
  • Per our database at Business Quant, Lifecore Biomedical's Income from Continuing Operations soared by 114.53% in 2024 and then crashed by 514.93% in 2025.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Income from Continuing Operations stood at -$23.4 million in 2021, then spiked by 33.97% to -$15.5 million in 2022, then crashed by 315.07% to -$64.2 million in 2023, then surged by 114.53% to $9.3 million in 2024, then tumbled by 514.93% to -$38.7 million in 2025.